Evidence map›Paper›PMID 26799613›Full record

ArticlePloS one2016

Structured Illumination Microscopy and a Quantitative Image Analysis for the Detection of Positive Margins in a Pre-Clinical Genetically Engineered Mouse Model of Sarcoma.

Henry L Fu, Jenna L Mueller, Melodi J Whitley, Diana M Cardona, Rebecca M Willett, David G Kirsch, J Quincy Brown, Nimmi Ramanujam

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Henry L FuDepartment of Biomedical Engineering, Duke University, Durham, North Carolina, United States of America.
Jenna L MuellerDepartment of Biomedical Engineering, Duke University, Durham, North Carolina, United States of America.
Melodi J WhitleyDepartment of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, North Carolina, United States of America.
Diana M CardonaDepartment of Pathology, Duke University School of Medicine, Durham, North Carolina, United States of America.
Rebecca M WillettDepartment of Electrical and Computer Engineering, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
David G KirschDepartment of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, North Carolina, United States of America.
J Quincy BrownDepartment of Biomedical Engineering, Tulane University, New Orleans, Louisiana, United States of America.
Nimmi RamanujamDepartment of Biomedical Engineering, Duke University, Durham, North Carolina, United States of America.
Duke University · USTulane University · USUniversity of Wisconsin–Madison · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2M
A Novel Optical Spectral Imaging System for Rapid Imaging of Breast Tumor MarginsR01EB011574 · NIBIB · DUKE UNIVERSITY · PI RAMANUJAM, NIRMALA · 2011 to 2015
$4.9M
A Fluorescence Histology System for In Vivo Breast Tumor Margin AssessmentR21CA159936 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI BROWN, JONATHAN QUINCY · 2011 to 2012
$448k
NCI NIH HHS R21 CA159936NIBIB NIH HHS 1R01EB011574-01NIBIB NIH HHS R01 EB011574NIGMS NIH HHS T32 GM007171
6 · The paper itself

Abstract

Intraoperative assessment of surgical margins is critical to ensuring residual tumor does not remain in a patient. Previously, we developed a fluorescence structured illumination microscope (SIM) system with a single-shot field of view (FOV) of 2.1 × 1.6 mm (3.4 mm2) and sub-cellular resolution (4.4 μm). The goal of this study was to test the utility of this technology for the detection of residual disease in a genetically engineered mouse model of sarcoma. Primary soft tissue sarcomas were generated in the hindlimb and after the tumor was surgically removed, the relevant margin was stained with acridine orange (AO), a vital stain that brightly stains cell nuclei and fibrous tissues. The tissues were imaged with the SIM system with the primary goal of visualizing fluorescent features from tumor nuclei. Given the heterogeneity of the background tissue (presence of adipose tissue and muscle), an algorithm known as maximally stable extremal regions (MSER) was optimized and applied to the images to specifically segment nuclear features. A logistic regression model was used to classify a tissue site as positive or negative by calculating area fraction and shape of the segmented features that were present and the resulting receiver operator curve (ROC) was generated by varying the probability threshold. Based on the ROC curves, the model was able to classify tumor and normal tissue with 77% sensitivity and 81% specificity (Youden's index). For an unbiased measure of the model performance, it was applied to a separate validation dataset that resulted in 73% sensitivity and 80% specificity. When this approach was applied to representative whole margins, for a tumor probability threshold of 50%, only 1.2% of all regions from the negative margin exceeded this threshold, while over 14.8% of all regions from the positive margin exceeded this threshold.

Indexed as

Disease Models, AnimalGenetic EngineeringAnimalsMiceMicroscopy, FluorescenceSarcoma

Identifiers

PMID26799613
PMCPMC4723137
OpenAlexW2215828019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.